Davita (NYSE:DVA) was upgraded by stock analysts at Citigroup from a “neutral” rating to a “buy” rating in a note issued to investors on Monday. The brokerage presently has a $82.00 price objective on the stock, up from their prior price objective of $67.71. Citigroup’s target price would indicate a potential upside of 16.48% from the company’s previous close.

Several other research firms have also issued reports on DVA. SunTrust Banks set a $70.00 price target on Davita and gave the stock a “hold” rating in a research report on Thursday, December 7th. Raymond James Financial upgraded Davita from an “outperform” rating to a “strong-buy” rating and raised their price target for the stock from $65.00 to $84.00 in a research report on Thursday, December 7th. J P Morgan Chase & Co raised their price target on Davita from $4.90 to $84.00 and gave the stock a “strong-buy” rating in a research report on Thursday, December 7th. KeyCorp restated a “hold” rating on shares of Davita in a research report on Wednesday, December 6th. Finally, Wolfe Research upgraded Davita from a “market perform” rating to an “outperform” rating in a research report on Monday, October 23rd. Three analysts have rated the stock with a sell rating, five have assigned a hold rating, three have given a buy rating and two have issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $73.33.

Davita (NYSE:DVA) opened at $70.40 on Monday. The company has a current ratio of 1.40, a quick ratio of 1.35 and a debt-to-equity ratio of 1.79. Davita has a 1 year low of $52.51 and a 1 year high of $70.58. The stock has a market capitalization of $12,814.77, a P/E ratio of 19.35, a P/E/G ratio of 13.65 and a beta of 0.97.

Davita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, November 7th. The company reported $0.81 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.94 by ($0.13). Davita had a return on equity of 13.31% and a net margin of 3.40%. The company had revenue of $3.92 billion for the quarter, compared to the consensus estimate of $3.91 billion. During the same quarter in the previous year, the business earned $0.95 earnings per share. Davita’s revenue was up 5.2% compared to the same quarter last year. analysts predict that Davita will post 3.42 earnings per share for the current year.

Davita announced that its Board of Directors has authorized a share buyback program on Tuesday, October 10th that allows the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board believes its shares are undervalued.

In related news, Chairman Kent J. Thiry sold 81,800 shares of Davita stock in a transaction that occurred on Friday, December 8th. The stock was sold at an average price of $68.04, for a total transaction of $5,565,672.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, VP Leanne M. Zumwalt sold 949 shares of Davita stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $68.19, for a total value of $64,712.31. Following the sale, the vice president now owns 12,423 shares in the company, valued at $847,124.37. The disclosure for this sale can be found here. Over the last quarter, insiders sold 110,889 shares of company stock worth $7,540,375. Corporate insiders own 2.00% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DVA. Canada Pension Plan Investment Board boosted its position in shares of Davita by 33.1% during the second quarter. Canada Pension Plan Investment Board now owns 387,370 shares of the company’s stock valued at $25,086,000 after purchasing an additional 96,282 shares in the last quarter. Pzena Investment Management LLC boosted its position in shares of Davita by 2.1% during the second quarter. Pzena Investment Management LLC now owns 3,398 shares of the company’s stock valued at $220,000 after purchasing an additional 71 shares in the last quarter. Airain ltd bought a new stake in shares of Davita during the second quarter valued at approximately $2,234,000. Jensen Investment Management Inc. boosted its position in shares of Davita by 24.2% during the second quarter. Jensen Investment Management Inc. now owns 9,740 shares of the company’s stock valued at $631,000 after purchasing an additional 1,900 shares in the last quarter. Finally, Schroder Investment Management Group boosted its position in shares of Davita by 53.9% during the second quarter. Schroder Investment Management Group now owns 49,967 shares of the company’s stock valued at $3,201,000 after purchasing an additional 17,497 shares in the last quarter. Institutional investors own 85.32% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.thecerbatgem.com/2017/12/13/citigroup-upgrades-davita-dva-to-buy.html.

Davita Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Analyst Recommendations for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.